<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-36251" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Juvenile Myoclonic Epilepsy</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Amrutkar</surname>
            <given-names>Chaitanya V.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Riel-Romero</surname>
            <given-names>Rosario M.</given-names>
          </name>
          <aff>Louisiana State University in Shreveport</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Chaitanya Amrutkar declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Rosario Riel-Romero declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>2</day>
          <month>2</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-36251.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Juvenile myoclonic epilepsy (JME), otherwise known as Janz syndrome and impulsive petit mal, is an idiopathic, hereditary, and generalized form of epilepsy. It was first described by Herpin in 1867, later on by Janz and Christian in 1957 as 'impulsive petit mal,' and by Lund in 1975 as JME. Its characteristics are the presence of absence, myoclonic, and generalized tonic-clonic seizures. JME falls into the classification of an idiopathic as well as hereditary (positive family history in approximately 50% of cases) disorder. JME is one of the most common childhood/juvenile epilepsy syndromes accounting for approximately 5%-10% of all cases of epilepsy. JME is seen in both sexes equally, although some studies have reported a higher incidence in females. JME usually manifests between 12 and 18 years of age. JME has both idiopathic and hereditary components. The genetics of inheritance is not fully understood, but a multifactorial mechanism is suspected. CACNB4, EFHC1, GABRA1 are some of the genes that carry known associations with JME. Although magnetic resonance imaging (MRI) of the brain is unremarkable in classic JME cases, there are reports of structural defects as a possible cause of JME. This activity reviews the evaluation and treatment of juvenile myoclonic epilepsy and the role of the interprofessional team in managing this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the frequency of juvenile myoclonic epilepsy.</p></list-item><list-item><p>Describe the epidemiology of juvenile myoclonic epilepsy in males compared to females.</p></list-item><list-item><p>Review the possible causes of juvenile myoclonic epilepsy.</p></list-item><list-item><p>Summarize the evaluation and treatment of juvenile myoclonic epilepsy and the role of the interprofessional team in managing this condition.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=36251&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=36251">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-36251.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Juvenile myoclonic epilepsy (JME), otherwise known as Janz syndrome and&#x000a0;impulsive petit mal, is an idiopathic, hereditary, and generalized form of epilepsy. It was first described by Herpin in 1867, later on by Janz and Christian in 1957 as 'impulsive petit&#x000a0;mal,' and by Lund in 1975 as JME. Its characteristics are the&#x000a0;presence of&#x000a0;absence, myoclonic, and generalized tonic-clonic seizures.</p>
      </sec>
      <sec id="article-36251.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>JME falls into the classification of an idiopathic as well as&#x000a0;hereditary (positive family history in approximately 50% of cases) disorder.</p>
      </sec>
      <sec id="article-36251.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>JME is one of the most common childhood/juvenile epilepsy syndromes accounting for approximately 5%-10% of all cases of epilepsy.<xref ref-type="bibr" rid="article-36251.r1">[1]</xref><xref ref-type="bibr" rid="article-36251.r2">[2]</xref> JME is seen in both sexes equally, although some studies have reported a higher incidence in females.<xref ref-type="bibr" rid="article-36251.r3">[3]</xref> JME usually manifests between&#x000a0;12 and 18 years of age.<xref ref-type="bibr" rid="article-36251.r4">[4]</xref></p>
      </sec>
      <sec id="article-36251.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The pathophysiology of JME has both idiopathic and hereditary components. The genetics of inheritance is not fully understood, but a multifactorial mechanism is suspected. CACNB4, EFHC1, GABRA1 are some of the genes that carry known associations with JME.<xref ref-type="bibr" rid="article-36251.r5">[5]</xref><xref ref-type="bibr" rid="article-36251.r6">[6]</xref> Although magnetic resonance imaging (MRI) of the brain is unremarkable in classic JME cases, there are reports of structural defects as a possible cause of JME.<xref ref-type="bibr" rid="article-36251.r7">[7]</xref><xref ref-type="bibr" rid="article-36251.r8">[8]</xref><xref ref-type="bibr" rid="article-36251.r9">[9]</xref></p>
      </sec>
      <sec id="article-36251.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The majority of patients with JME start having seizures between the age of 12 to 18 with a mean age of onset around 15 years. But, the onset can be early or later with an age range between 5-34 years.<xref ref-type="bibr" rid="article-36251.r4">[4]</xref><xref ref-type="bibr" rid="article-36251.r10">[10]</xref> As mentioned in the introduction, JME is&#x000a0;characterized&#x000a0;by&#x000a0;the&#x000a0;presence of&#x000a0;absence, myoclonic, and generalized tonic-clonic (GTC) seizures. All patients with JME have myoclonic seizures, 85%-90% of patients have GTC seizures, and about 20-40% of patients have absence seizures.<xref ref-type="bibr" rid="article-36251.r10">[10]</xref><xref ref-type="bibr" rid="article-36251.r11">[11]</xref><xref ref-type="bibr" rid="article-36251.r12">[12]</xref></p>
        <p>Myoclonic seizures are the&#x000a0;hallmark of this condition and are necessary for the diagnosis of JME. Only occasionally they will manifest as the only seizure type. They&#x000a0;are described as brief, usually bilateral, jerking movements of the arms and sometimes legs with preservation of consciousness. The misdiagnosis of myoclonic seizures is possible as twitches or anxiety/nervousness. Many&#x000a0;a time, increasing intensity and frequency of myoclonic jerks in clusters evolve into GTC seizures. GTC seizures usually occur a few months after the onset of myoclonic seizures. Absence seizures are generally the first seizures to manifest in JME. They tend to&#x000a0;occur 3 to 5 years before the onset of myoclonic or GTC seizures, sometimes as early as 5 to 6 years of age.&#x000a0;The early and isolated occurrence of absence seizures frequently leads to a diagnosis of childhood or juvenile absence epilepsy.&#x000a0;Seizures with JME occur 30 minutes to an hour after morning awakening, especially the myoclonic seizures. Usual triggers for JME are sleep deprivation, alcohol intake, emotional stress, anxiety, fatigue. A large proportion&#x000a0;(30%-40%) of JME patients exhibit photosensitivity and flashing lights, sunlight, TV, and computer can trigger seizures. Photosensitive patients tend to&#x000a0;have an&#x000a0;earlier onset of seizures.</p>
        <p>Physical examination remains normal, and cognition well preserved. Studies suggest an increased prevalence of psychiatric disorders, including anxiety, mood disorder, and personality disorders in patients with JME.<xref ref-type="bibr" rid="article-36251.r13">[13]</xref><xref ref-type="bibr" rid="article-36251.r14">[14]</xref><xref ref-type="bibr" rid="article-36251.r15">[15]</xref></p>
      </sec>
      <sec id="article-36251.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>History provides most of the clues necessary for a diagnosis of JME. Physical examination is generally&#x000a0;unremarkable. An electroencephalogram (EEG) provides supporting evidence for diagnosing JME.&#x000a0;An interictal EEG is abnormal in the majority of patients with JME.<xref ref-type="bibr" rid="article-36251.r16">[16]</xref> If the routine EEG is normal, an overnight and sleep-deprived EEG is abnormal in almost every patient. The abnormalities are seen mostly&#x000a0;during the transition from sleep to awakening.<xref ref-type="bibr" rid="article-36251.r17">[17]</xref> The typical EEG in JME shows diffuse, symmetric, bilateral 4 to 6 hertz (Hz)&#x000a0;polyspike and wave discharges with a fronto-central predominance. The background has normal alpha rhythm, and approximately half of the patient population will have focal or asymmetric abnormalities.<xref ref-type="bibr" rid="article-36251.r18">[18]</xref> Ictal or continuous EEG recording shows 10-16 Hz polyspike discharges&#x000a0;with myoclonic jerks. The spikes correlate with myoclonic jerks.<xref ref-type="bibr" rid="article-36251.r19">[19]</xref> The EEG findings in GTC (low voltage fast activity with spike and wave discharges) and absence seizures (generalized 3 Hz spike and wave discharges) associated with JME&#x000a0;are similar to those seen with other epilepsies. Since it is known to be photosensitive epilepsy, photic stimulation provides enhanced yield on EEG in JME.&#x000a0;</p>
        <p>If history, examination, and EEG are indicative of JME, imaging (with&#x000a0;magnetic resonance imaging-MRI) is usually unnecessary as it&#x000a0;tends to be normal.<xref ref-type="bibr" rid="article-36251.r20">[20]</xref> Although, there are reports/studies about structural abnormalities in the cortex and subcortical gray matter in JME patients. There have been&#x000a0;reports on JME patients showing abnormalities on electrophysiological tests and advanced imaging techniques such as magnetic resonance spectroscopy (MRS) and positron emission tomography (PET)&#x000a0;as well.&#x000a0;</p>
      </sec>
      <sec id="article-36251.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>JME is relatively easy to control with anti-epilepsy drugs (AEDs), and most patients respond to monotherapy. Valproic acid is the most effective medication and drug of choice for treatment of JME.<xref ref-type="bibr" rid="article-36251.r21">[21]</xref> It is a&#x000a0;broad-spectrum medication and treats all seizure types of JME. Its use requires a great deal of caution in women of childbearing age,&#x000a0;given its well known teratogenic potential.<xref ref-type="bibr" rid="article-36251.r22">[22]</xref> Other treatment options include levetiracetam, lamotrigine, topiramate, and&#x000a0;zonisamide.<xref ref-type="bibr" rid="article-36251.r23">[23]</xref><xref ref-type="bibr" rid="article-36251.r24">[24]</xref><xref ref-type="bibr" rid="article-36251.r25">[25]</xref><xref ref-type="bibr" rid="article-36251.r26">[26]</xref><xref ref-type="bibr" rid="article-36251.r27">[27]</xref> Lamotrigine can lead to a worsening in myoclonic seizures but is still widely used for the treatment of JME as it controls the other seizure types.<xref ref-type="bibr" rid="article-36251.r23">[23]</xref><xref ref-type="bibr" rid="article-36251.r28">[28]</xref> If only absence seizures are present, ethosuximide can be a therapy choice. Clonazepam&#x000a0;is effective against myoclonic jerks.&#x000a0;Contraindicated agents include carbamazepine, oxcarbazepine, phenytoin (sodium channel blocking agents), given their potential to exacerbate myoclonic and absence seizures. But, they can be useful for the treatment of GTC seizures in JME.<xref ref-type="bibr" rid="article-36251.r29">[29]</xref> Other medications to avoid include vigabatrin, tiagabine, gabapentin, pregabalin, and primidone.<xref ref-type="bibr" rid="article-36251.r30">[30]</xref> JME is intractable in only a few patients, and combination therapy with or without&#x000a0;vagus nerve stimulation (VNS) is an option in such cases.<xref ref-type="bibr" rid="article-36251.r31">[31]</xref></p>
      </sec>
      <sec id="article-36251.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Many other epilepsy syndromes have similar features and resemble JME at various stages of their progression. Differential diagnosis includes childhood or juvenile absence epilepsy, eyelid myoclonia with absences, progressive myoclonic epilepsy, photosensitive occipital epilepsy, epilepsy with grand mal seizures upon awakening, hypnogogic myoclonus (hypnic jerk), and non-epileptic seizures.&#x000a0;</p>
      </sec>
      <sec id="article-36251.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Seizures are usually well controlled with medications in a great majority of patients with JME and generally improve after the fourth decade of life.<xref ref-type="bibr" rid="article-36251.r32">[32]</xref> But, JME requires lifelong treatment (even after a long seizure-free interval), as the chances of relapse are high&#x000a0;if medications are discontinued.<xref ref-type="bibr" rid="article-36251.r33">[33]</xref></p>
      </sec>
      <sec id="article-36251.s11" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>While JME management is chiefly under a neurologist, the follow up is usually under the primary caregiver or nurse practitioner. The key to the prevention of seizures is patient education by the interprofessional team.&#x000a0;Pharmacists should educate patients and their families about the importance of compliance and side effects. Neuroscience nurses monitor patients, educate, and keep the team informed as to changes in status. [Level 5]</p>
        <p>Avoidance of precipitating factors/triggers should be a strong emphasis. These include avoiding alcohol use, fatigue, stress, sleep deprivation, flashing lights in any form, medication non-compliance, hunger, extremes of temperature, drug use. Patients should also be advised/educated with precautions regarding driving, operating heavy machinery, swimming, avoiding heights/being near fires alone.&#x000a0;The treatment is usually life long&#x000a0;(even after a long seizure-free interval), as the chances of relapse are high&#x000a0;if medications are discontinued.<xref ref-type="bibr" rid="article-36251.r33">[33]</xref> As with any epilepsy syndrome, risks versus benefits&#x000a0;of medications during pregnancy should be a point of discussion in detail with the patient.</p>
      </sec>
      <sec id="article-36251.s12">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=36251&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=36251">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/child-health/juvenile-myoclonic-epilepsy/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=36251">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/36251/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=36251">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-36251.s13">
        <fig id="article-36251.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Juvenile Myoclonic Epilepsy Contributed by Chaitanya Amrutkar, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="JME" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-36251.s14">
        <title>References</title>
        <ref id="article-36251.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Panayiotopoulos</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Obeid</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tahan</surname>
                <given-names>AR</given-names>
              </name>
            </person-group>
            <article-title>Juvenile myoclonic epilepsy: a 5-year prospective study.</article-title>
            <source>Epilepsia</source>
            <year>1994</year>
            <season>Mar-Apr</season>
            <volume>35</volume>
            <issue>2</issue>
            <fpage>285</fpage>
            <page-range>285-96</page-range>
            <pub-id pub-id-type="pmid">8156946</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36251.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hauser</surname>
                <given-names>WA</given-names>
              </name>
            </person-group>
            <article-title>The prevalence and incidence of convulsive disorders in children.</article-title>
            <source>Epilepsia</source>
            <year>1994</year>
            <volume>35 Suppl 2</volume>
            <fpage>S1</fpage>
            <page-range>S1-6</page-range>
            <pub-id pub-id-type="pmid">8275976</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36251.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Janz</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Epilepsy with impulsive petit mal (juvenile myoclonic epilepsy).</article-title>
            <source>Acta Neurol Scand</source>
            <year>1985</year>
            <month>Nov</month>
            <volume>72</volume>
            <issue>5</issue>
            <fpage>449</fpage>
            <page-range>449-59</page-range>
            <pub-id pub-id-type="pmid">3936330</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36251.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Canevini</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Mai</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Di Marco</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bertin</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Minotti</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Pontrelli</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Saltarelli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Canger</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Juvenile myoclonic epilepsy of Janz: clinical observations in 60 patients.</article-title>
            <source>Seizure</source>
            <year>1992</year>
            <month>Dec</month>
            <volume>1</volume>
            <issue>4</issue>
            <fpage>291</fpage>
            <page-range>291-8</page-range>
            <pub-id pub-id-type="pmid">1344779</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36251.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Buraei</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>The &#x000df; subunit of voltage-gated Ca2+ channels.</article-title>
            <source>Physiol Rev</source>
            <year>2010</year>
            <month>Oct</month>
            <volume>90</volume>
            <issue>4</issue>
            <fpage>1461</fpage>
            <page-range>1461-506</page-range>
            <pub-id pub-id-type="pmid">20959621</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36251.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Delgado-Escueta</surname>
                <given-names>AV</given-names>
              </name>
              <name>
                <surname>Koeleman</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Bailey</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Medina</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Dur&#x000f3;n</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>The quest for juvenile myoclonic epilepsy genes.</article-title>
            <source>Epilepsy Behav</source>
            <year>2013</year>
            <month>Jul</month>
            <volume>28 Suppl 1</volume>
            <fpage>S52</fpage>
            <page-range>S52-7</page-range>
            <pub-id pub-id-type="pmid">23756480</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36251.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Concha</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Beaulieu</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gross</surname>
                <given-names>DW</given-names>
              </name>
            </person-group>
            <article-title>Distinct white matter abnormalities in different idiopathic generalized epilepsy syndromes.</article-title>
            <source>Epilepsia</source>
            <year>2011</year>
            <month>Dec</month>
            <volume>52</volume>
            <issue>12</issue>
            <fpage>2267</fpage>
            <page-range>2267-75</page-range>
            <pub-id pub-id-type="pmid">22092238</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36251.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tae</surname>
                <given-names>WS</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Joo</surname>
                <given-names>EY</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>IY</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>SI</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Hong</surname>
                <given-names>SB</given-names>
              </name>
            </person-group>
            <article-title>Cortical thickness abnormality in juvenile myoclonic epilepsy.</article-title>
            <source>J Neurol</source>
            <year>2008</year>
            <month>Apr</month>
            <volume>255</volume>
            <issue>4</issue>
            <fpage>561</fpage>
            <page-range>561-6</page-range>
            <pub-id pub-id-type="pmid">18227991</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36251.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mory</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Betting</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>Fernandes</surname>
                <given-names>PT</given-names>
              </name>
              <name>
                <surname>Lopes-Cendes</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Guerreiro</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Guerreiro</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Cendes</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>LM</given-names>
              </name>
            </person-group>
            <article-title>Structural abnormalities of the thalamus in juvenile myoclonic epilepsy.</article-title>
            <source>Epilepsy Behav</source>
            <year>2011</year>
            <month>Aug</month>
            <volume>21</volume>
            <issue>4</issue>
            <fpage>407</fpage>
            <page-range>407-11</page-range>
            <pub-id pub-id-type="pmid">21700499</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36251.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vijai</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cherian</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Stlaja</surname>
                <given-names>PN</given-names>
              </name>
              <name>
                <surname>Anand</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Radhakrishnan</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Clinical characteristics of a South Indian cohort of juvenile myoclonic epilepsy probands.</article-title>
            <source>Seizure</source>
            <year>2003</year>
            <month>Oct</month>
            <volume>12</volume>
            <issue>7</issue>
            <fpage>490</fpage>
            <page-range>490-6</page-range>
            <pub-id pub-id-type="pmid">12967578</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36251.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jayalakshmi</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Srinivasa Rao</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Sailaja</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Focal clinical and electroencephalographic features in patients with juvenile myoclonic epilepsy.</article-title>
            <source>Acta Neurol Scand</source>
            <year>2010</year>
            <month>Aug</month>
            <volume>122</volume>
            <issue>2</issue>
            <fpage>115</fpage>
            <page-range>115-23</page-range>
            <pub-id pub-id-type="pmid">19845556</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36251.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Murthy</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Rao</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Meena</surname>
                <given-names>AK</given-names>
              </name>
            </person-group>
            <article-title>Clinical observations of juvenile myoclonic epilepsy in 131 patients: a study in South India.</article-title>
            <source>Seizure</source>
            <year>1998</year>
            <month>Feb</month>
            <volume>7</volume>
            <issue>1</issue>
            <fpage>43</fpage>
            <page-range>43-7</page-range>
            <pub-id pub-id-type="pmid">9548225</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36251.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Trinka</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kienpointner</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Unterberger</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Luef</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bauer</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Doering</surname>
                <given-names>LB</given-names>
              </name>
              <name>
                <surname>Doering</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Psychiatric comorbidity in juvenile myoclonic epilepsy.</article-title>
            <source>Epilepsia</source>
            <year>2006</year>
            <month>Dec</month>
            <volume>47</volume>
            <issue>12</issue>
            <fpage>2086</fpage>
            <page-range>2086-91</page-range>
            <pub-id pub-id-type="pmid">17201708</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36251.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moschetta</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fiore</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Fuentes</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gois</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Valente</surname>
                <given-names>KD</given-names>
              </name>
            </person-group>
            <article-title>Personality traits in patients with juvenile myoclonic epilepsy.</article-title>
            <source>Epilepsy Behav</source>
            <year>2011</year>
            <month>Aug</month>
            <volume>21</volume>
            <issue>4</issue>
            <fpage>473</fpage>
            <page-range>473-7</page-range>
            <pub-id pub-id-type="pmid">21683658</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36251.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Somayajula</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Vooturi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jayalakshmi</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Psychiatric disorders among 165 patients with juvenile myoclonic epilepsy in India and association with clinical and sociodemographic variables.</article-title>
            <source>Epilepsy Behav</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>53</volume>
            <fpage>37</fpage>
            <page-range>37-42</page-range>
            <pub-id pub-id-type="pmid">26519664</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36251.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baise-Zung</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Guilhoto</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Grossmann</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>Juvenile myoclonic epilepsy: non-classic electroencephalographical presentation in adult patients.</article-title>
            <source>Eur J Neurol</source>
            <year>2006</year>
            <month>Feb</month>
            <volume>13</volume>
            <issue>2</issue>
            <fpage>171</fpage>
            <page-range>171-5</page-range>
            <pub-id pub-id-type="pmid">16490048</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36251.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dhanuka</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Jain</surname>
                <given-names>BK</given-names>
              </name>
              <name>
                <surname>Daljit</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Maheshwari</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Juvenile myoclonic epilepsy: a clinical and sleep EEG study.</article-title>
            <source>Seizure</source>
            <year>2001</year>
            <month>Jul</month>
            <volume>10</volume>
            <issue>5</issue>
            <fpage>374</fpage>
            <page-range>374-8</page-range>
            <pub-id pub-id-type="pmid">11488650</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36251.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>L&#x000e9;tourneau</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Cieuta-Walti</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Deacon</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Epileptiform asymetries and treatment response in juvenile myoclonic epilepsy.</article-title>
            <source>Can J Neurol Sci</source>
            <year>2010</year>
            <month>Nov</month>
            <volume>37</volume>
            <issue>6</issue>
            <fpage>826</fpage>
            <page-range>826-30</page-range>
            <pub-id pub-id-type="pmid">21059546</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36251.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hrachovy</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Frost</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>The EEG in selected generalized seizures.</article-title>
            <source>J Clin Neurophysiol</source>
            <year>2006</year>
            <month>Aug</month>
            <volume>23</volume>
            <issue>4</issue>
            <fpage>312</fpage>
            <page-range>312-32</page-range>
            <pub-id pub-id-type="pmid">16885706</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36251.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Anderson</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hamandi</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Understanding juvenile myoclonic epilepsy: contributions from neuroimaging.</article-title>
            <source>Epilepsy Res</source>
            <year>2011</year>
            <month>May</month>
            <volume>94</volume>
            <issue>3</issue>
            <fpage>127</fpage>
            <page-range>127-37</page-range>
            <pub-id pub-id-type="pmid">21482074</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36251.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chowdhury</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Brodie</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Pharmacological outcomes in juvenile myoclonic epilepsy: Support for sodium valproate.</article-title>
            <source>Epilepsy Res</source>
            <year>2016</year>
            <month>Jan</month>
            <volume>119</volume>
            <fpage>62</fpage>
            <page-range>62-6</page-range>
            <pub-id pub-id-type="pmid">26675554</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36251.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tomson</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Battino</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Perucca</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Valproic acid after five decades of use in epilepsy: time to reconsider the indications of a time-honoured drug.</article-title>
            <source>Lancet Neurol</source>
            <year>2016</year>
            <month>Feb</month>
            <volume>15</volume>
            <issue>2</issue>
            <fpage>210</fpage>
            <page-range>210-218</page-range>
            <pub-id pub-id-type="pmid">26655849</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36251.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bodenstein-Sachar</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Gandelman-Marton</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ben-Zeev</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Chapman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Blatt</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Outcome of lamotrigine treatment in juvenile myoclonic epilepsy.</article-title>
            <source>Acta Neurol Scand</source>
            <year>2011</year>
            <month>Jul</month>
            <volume>124</volume>
            <issue>1</issue>
            <fpage>22</fpage>
            <page-range>22-7</page-range>
            <pub-id pub-id-type="pmid">21208196</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36251.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Verrotti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cerminara</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Coppola</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Franzoni</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Parisi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Iannetti</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Aloisi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Tozzi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Cusmai</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Vigevano</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Chiarelli</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Curatolo</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Levetiracetam in juvenile myoclonic epilepsy: long-term efficacy in newly diagnosed adolescents.</article-title>
            <source>Dev Med Child Neurol</source>
            <year>2008</year>
            <month>Jan</month>
            <volume>50</volume>
            <issue>1</issue>
            <fpage>29</fpage>
            <page-range>29-32</page-range>
            <pub-id pub-id-type="pmid">18173626</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36251.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Levisohn</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Holland</surname>
                <given-names>KD</given-names>
              </name>
            </person-group>
            <article-title>Topiramate or valproate in patients with juvenile myoclonic epilepsy: a randomized open-label comparison.</article-title>
            <source>Epilepsy Behav</source>
            <year>2007</year>
            <month>Jun</month>
            <volume>10</volume>
            <issue>4</issue>
            <fpage>547</fpage>
            <page-range>547-52</page-range>
            <pub-id pub-id-type="pmid">17482520</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36251.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>LN</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>YP</given-names>
              </name>
            </person-group>
            <article-title>Topiramate monotherapy for juvenile myoclonic epilepsy.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2015</year>
            <month>Dec</month>
            <day>23</day>
            <issue>12</issue>
            <fpage>CD010008</fpage>
            <pub-id pub-id-type="pmid">26695884</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36251.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kothare</surname>
                <given-names>SV</given-names>
              </name>
              <name>
                <surname>Valencia</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Khurana</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Hardison</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Melvin</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Legido</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy.</article-title>
            <source>Epileptic Disord</source>
            <year>2004</year>
            <month>Dec</month>
            <volume>6</volume>
            <issue>4</issue>
            <fpage>267</fpage>
            <page-range>267-70</page-range>
            <pub-id pub-id-type="pmid">15634623</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36251.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Biraben</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Allain</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Scarabin</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Sch&#x000fc;ck</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Edan</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Exacerbation of juvenile myoclonic epilepsy with lamotrigine.</article-title>
            <source>Neurology</source>
            <year>2000</year>
            <month>Dec</month>
            <day>12</day>
            <volume>55</volume>
            <issue>11</issue>
            <fpage>1758</fpage>
            <pub-id pub-id-type="pmid">11113246</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36251.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Knott</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Panayiotopoulos</surname>
                <given-names>CP</given-names>
              </name>
            </person-group>
            <article-title>Carbamazepine in the treatment of generalised tonic clonic seizures in juvenile myoclonic epilepsy.</article-title>
            <source>J Neurol Neurosurg Psychiatry</source>
            <year>1994</year>
            <month>Apr</month>
            <volume>57</volume>
            <issue>4</issue>
            <fpage>503</fpage>
            <pub-id pub-id-type="pmid">8164005</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36251.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mantoan</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Walker</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Treatment options in juvenile myoclonic epilepsy.</article-title>
            <source>Curr Treat Options Neurol</source>
            <year>2011</year>
            <month>Aug</month>
            <volume>13</volume>
            <issue>4</issue>
            <fpage>355</fpage>
            <page-range>355-70</page-range>
            <pub-id pub-id-type="pmid">21494841</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36251.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kostov</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Larsson</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>R&#x000f8;ste</surname>
                <given-names>GK</given-names>
              </name>
            </person-group>
            <article-title>Is vagus nerve stimulation a treatment option for patients with drug-resistant idiopathic generalized epilepsy?</article-title>
            <source>Acta Neurol Scand Suppl</source>
            <year>2007</year>
            <volume>187</volume>
            <fpage>55</fpage>
            <page-range>55-8</page-range>
            <pub-id pub-id-type="pmid">17419830</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36251.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baykan</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Altindag</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Bebek</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ozturk</surname>
                <given-names>AY</given-names>
              </name>
              <name>
                <surname>Aslantas</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Gurses</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Baral-Kulaksizoglu</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Gokyigit</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Myoclonic seizures subside in the fourth decade in juvenile myoclonic epilepsy.</article-title>
            <source>Neurology</source>
            <year>2008</year>
            <month>May</month>
            <day>27</day>
            <volume>70</volume>
            <issue>22 Pt 2</issue>
            <fpage>2123</fpage>
            <page-range>2123-9</page-range>
            <pub-id pub-id-type="pmid">18505992</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36251.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mart&#x000ed;nez-Ju&#x000e1;rez</surname>
                <given-names>IE</given-names>
              </name>
              <name>
                <surname>Alonso</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Medina</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Dur&#x000f3;n</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Bailey</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>L&#x000f3;pez-Ruiz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ramos-Ram&#x000ed;rez</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Le&#x000f3;n</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Pineda</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Castroviejo</surname>
                <given-names>IP</given-names>
              </name>
              <name>
                <surname>Silva</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mija</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Perez-Gosiengfiao</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Machado-Salas</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Delgado-Escueta</surname>
                <given-names>AV</given-names>
              </name>
            </person-group>
            <article-title>Juvenile myoclonic epilepsy subsyndromes: family studies and long-term follow-up.</article-title>
            <source>Brain</source>
            <year>2006</year>
            <month>May</month>
            <volume>129</volume>
            <issue>Pt 5</issue>
            <fpage>1269</fpage>
            <page-range>1269-80</page-range>
            <pub-id pub-id-type="pmid">16520331</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
